PSI CRO
PSI CRO is a global clinical research organization specializing in therapeutic areas such as Oncology, Hematology, and Rare Diseases, known for delivering clinical trials on time and on budget.
Global Operations
PSI CRO operates internationally, focusing on delivering clinical trials on time and within budget. Their global reach allows them to manage trials across various geographical locations, ensuring a consistent and uniform approach to clinical research.
Therapeutic Specializations
PSI CRO specializes in various therapeutic areas, including Oncology, Hematology, Infectious Diseases, Multiple Sclerosis, and Rare Diseases. This specialization enables them to provide targeted and effective clinical trial management specific to these fields.
Proprietary Technology Platform
PSI CRO utilizes a proprietary technology platform designed to aid in clinical trial planning, budgeting, and financial tracking. This platform streamlines processes and enhances the efficiency and accuracy of clinical trial management.
CRO Leadership Awards 2024
In 2024, PSI CRO received CRO Leadership Awards for Expertise, Quality, Compatibility, and Reliability. These awards recognize the company's commitment to excellence and its ability to consistently deliver high-quality services.
Partnership with Medidata
PSI CRO partners with Medidata to expand its data-driven feasibility capabilities for clinical trials. This collaboration enhances their ability to conduct comprehensive and accurate feasibility assessments, improving trial outcomes.
Asia-Pacific Expansion
PSI CRO continues to grow its presence in the Asia-Pacific region with the establishment of a new office in Bangkok, Thailand. This expansion supports their global operations and increases their ability to manage clinical trials in this key region.